Immune synergistic oligodeoxynucleotide from Lactobacillus rhamnosus GG enhances the immune response upon co-stimulation by bacterial and fungal cell wall components

Animal Science Journal = Nihon Chikusan Gakkaihō
Shireen NigarTakeshi Shimosato

Abstract

Bacterial genomic DNA has recently been shown to elicit a highly evolved immune defense. This response can be selectively triggered for a wide range of therapeutic applications, including use as a vaccine adjuvant to immunotherapies for allergy, cancer, and infectious diseases. Previously, we identified a low-concentration immune synergistic oligodeoxynucleotide (iSN-ODN, named iSN34) from Lactobacillus rhamnosus GG that has immunosynergistic activity upon costimulation of target cells with ligands of Toll-like receptor 9 (TLR9). Here, we extend that observation by demonstrating the synergistic induction (in mouse splenocytes) of IL-6 by the combination of iSN34 with cell wall components of bacteria and fungi. We observed that splenocytes pretreated with iSN34 and then costimulated with agonists for TLR1/2 (Pam3 CSK4 ), TLR4 (lipopolysaccharide), or TLR2/6 (Zymosan) exhibited enhanced accumulation of IL-6. These results suggested that the combination of iSN34 with TLR1/2, TLR4, or TLR2/6 agonists may permit the induction of a potent immune response.

References

Mar 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S AkashiK Miyake
Aug 15, 2001·Acta Odontologica Scandinavica·T Kaisho, S Akira
Sep 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·F TakeshitaD M Klinman
Feb 28, 2002·Annual Review of Immunology·Arthur M Krieg
Sep 11, 2002·Cytokine & Growth Factor Reviews·Katsuhiko Ishihara, Toshio Hirano
Apr 30, 2003·The Journal of Experimental Medicine·Benjamin N GantnerDavid M Underhill
Sep 17, 2004·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·A WedrychowiczA Wedrychowicz
Jun 7, 2005·Advances in Experimental Medicine and Biology·Karen M Haas, Thomas F Tedder
Jun 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Manish PatelFoo Y Liew
Feb 25, 2006·Cell·Shizuo AkiraOsamu Takeuchi
Aug 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·James W WellsAlistair Noble
Feb 28, 2009·International Immunology·Taro Kawai, Shizuo Akira
Apr 16, 2009·Clinical Microbiology Reviews·Trine H Mogensen
Oct 3, 2009·Nature Reviews. Rheumatology·Thomas F Tedder
Jan 14, 2010·Immunology·Isabelle Bekeredjian-Ding, Gaetan Jego
Nov 19, 2011·Nature Reviews. Immunology·Kingston H G Mills
Nov 20, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katie MatthewsRogier W Sanders
Dec 6, 2012·Experimental Hematology & Oncology·Kemeng WangDelong Liu
May 23, 2014·Immunologic Research·Claire M Buchta, Gail A Bishop
Dec 17, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yeqin WangTakeshi Shimosato
Oct 6, 2017·BMC Immunology·Shireen NigarTakeshi Shimosato

❮ Previous
Next ❯

Citations

Sep 12, 2019·Frontiers in Nutrition·Shireen Nigar, Takeshi Shimosato
Aug 8, 2020·Animal Science Journal = Nihon Chikusan Gakkaihō·Masami TsukagoshiTakeshi Shimosato

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.